According to the US Food and Drug Administration (FDA), Precision Medicine, or “personalised medicine”, is a new way of tailoring disease care by considering people’s unique genes, environments, and lifestyles. The goal is to give the right treatments at the right time.
Read More
Expectant parents in Europe will soon have access to leading prenatal testing kits that are widely utilised in Australia to diagnose a range of life quality impacting diseases, including Down Syndrome, courtesy of biotech company Genetic Technologies (ASX: GTG) expanding their test kit distribution into Europe. Mothers-to-be typically perform a Non-Invasive Prenatal Test (NIPT) any
Read More
The one-size-fits-all approach to medicine is on its way out with the rise of personalised medicine. The development of technologies to individualise healthcare for each person holds much promise for tackling disease treatment and prevention. A prime example of this is the development of genetic testing for the BRCA genes. Inherited genetic mutations within these
Read More